AAKP Meets With Centers For Medicare And Medicaid Services Regarding Passage Of Mippa And Chronic Kidney Disease Education
Main Category: Medicare / Medicaid / SCHIPAlso Included In: Urology / Nephrology
Article Date: 01 Jun 2009 - 2:00 PDT
| Patient / Public: | ![]() |
4 (2 votes) |
| Healthcare Prof: | ![]() |
On Tuesday, May 26, 2009, the American Association of Kidney Patients' (AAKP) Executive Director Kim Buettner and members of the AAKP Board of Directors met with staff members of the Centers for Medicare and Medicaid Services (CMS) regarding the passage of the Medicare Improvement for Patients and Providers Act (MIPPA) on chronic kidney disease (CKD) education. MIPPA provides for Medicare coverage of up to six sessions of education for individuals with CKD in stage 4. The education includes instructions on the management of co-morbidities, with the goal of delaying the need for dialysis and discussion on the treatment options available to patients for renal replacement therapy.
Buettner told members of CMS AAKP is appreciative of the legislation and outlined important factors the Association believes should be considered. "We want to make sure patients are at the forefront of the minds of CMS staff members when they are drafting these laws," stated Buettner. "I think we were able to do that today by giving CMS staff members an opportunity to meet patients these laws will have a direct affect on."
AAKP is a national non-profit organization directed by patients for patients. Started 40 years ago by six dialysis patients, AAKP's mission is to raise awareness about kidney disease, educating patients, family members and the general public about the disease and its treatment options. In a letter, AAKP asked CMS to consider the following:
- The legislation (MIPPA) calls for a discussion of available treatment options. AAKP encourages fair, objective and equal access for all patients and family members to information about all forms of treatment options, including but not limited to: home therapies (hemodialysis and peritoneal dialysis), in-center hemodialysis (thrice weekly, nocturnal) and palliative care.
- The education delivered should be in agreement with patient and family centered care guidelines, which encourages providing health care information at the level the patient and family chooses.
- AAKP also asks you to consider how often a patient can receive this course of education. Only receiving this series of education once during a lifetime is not appropriate for patients. A patient who receives this education before receiving a transplant could easily need additional education if the transplant fails years later.
To read the complete letter AAKP sent to CMS, visit the AAKP Web site at www.aakp.org/public-policy/public-comments-correspondence or call (800) 749-AAKP for more information.
Source
AAKP
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/152046.php>
APA
http://www.medicalnewstoday.com/releases/152046.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





